Power Law company profile

Instil Bio

Biotech & Life Sciences · Dallas, United States · Founded 2008 · IPO 2021 Unicorn

Clinical-stage immuno-oncology company focused on developing patient specific immunotherapy

Valuation

$62M

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where Instil Bio has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States85.9%

🇬🇧 United Kingdom13%

🇧🇷 Brazil2.7%

3 countries shown

Web traffic by country

3K monthly visits
across markets

🇺🇸 United States76.7%

🇬🇧 United Kingdom20%

🇵🇱 Poland3.3%

Top 3 markets shown

Patent intelligence

$7M patent portfolio · 29 active families

Estimated portfolio value

$7M

10.9% of market cap · 35.4× smaller than top peer Juno Therapeutics ($239M)

29 active patent families

Where Instil Bio innovates Cell biologyMolecular biologyCell therapyAdoptive cellular therapyReceptor

Where Instil Bio concentrates vs peers

Each axis is a top-10 topic across Instil Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Instil Bio

An AI-synthesized read of the highest-engagement posts about Instil Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Instil Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles